Retatrutide 30mg - 2.6ml Research Compound peptide Pen
Weight Management • Appetite Control • Metabolic Support
Retatrutide 30mg / 2.6ml is a compounded peptide pen designed for precision dosing and advanced research applications. This pre-filled pen format is engineered for consistency, stability, and controlled delivery, making it suitable for structured laboratory and metabolic research environments.
Retatrutide is a triple receptor agonist compound associated with GLP-1, GIP, and glucagon receptor activity and is commonly studied in relation to metabolic pathways, energy regulation, appetite control, and glucose-related research models. The pen system supports accurate and repeatable dosing within controlled research protocols.
Key Benefits
- Triple receptor agonist (GLP-1, GIP, and glucagon) commonly researched in metabolic studies
- May support appetite regulation and satiety-related research models
- Frequently explored in energy balance and glucose metabolism research contexts
- Pre-filled 30mg / 2.6ml pen format for convenience and dosing accuracy
- Designed for consistent, controlled, and repeatable delivery in research applications
- Long-acting peptide profile suitable for extended experimental protocols
- Stable compounded formulation designed for reliability and handling ease
- Suitable for advanced laboratory and metabolic research workflows.
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
